Lantheus Holdings, Inc. LNTH
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 2015-06-25
Lantheus Holdings, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Ber Gerard | director | 2026-05-14 | Tax withheld | 381 | $96.67 |
| Heino Mary Anne | Executive Chair and CEO | 2026-05-14 | Tax withheld | 1,227 | $96.67 |
| McHugh Julie | director | 2026-05-14 | Grant | 4,137 | — |
| Morrow Phuong Khanh | director | 2026-05-14 | Grant | 4,137 | — |
| Maeusli Heinz Christoph | director | 2026-05-14 | Grant | 4,137 | — |
| LENO SAM R | director | 2026-05-14 | Grant | 4,137 | — |
| Pruden Gary J | director | 2026-05-14 | Grant | 4,137 | — |
| Baylor-Henry Minnie | director | 2026-05-14 | Grant | 4,137 | — |
Source: SEC EDGAR filings · CIK 0001521036 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.